RGNT (NYSEAMERICAN:RGNT) Upgraded at ThinkEquity

ThinkEquity upgraded shares of RGNT (NYSEAMERICAN:RGNTFree Report) to a strong-buy rating in a research note published on Monday morning,Zacks.com reports.

RGNT Price Performance

NYSEAMERICAN RGNT opened at $3.25 on Monday. RGNT has a 1-year low of $3.10 and a 1-year high of $8.35.

RGNT Company Profile

(Get Free Report)

Regentis Biomaterials Ltd. is a regenerative medicine company dedicated to developing tissue repair solutions which seek to restore the health. Regentis Biomaterials Ltd. is based in Herzliya, Israel.

See Also

Receive News & Ratings for RGNT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RGNT and related companies with MarketBeat.com's FREE daily email newsletter.